Injecting Room

When ‘Supervised’ Doesn’t Mean Safe: A Snapshot on Canadian Drug Consumption Facilities.

Supervised consumption sites were sold as a disciplined, tightly monitored answer to the overdose crisis. In Alberta, the evidence suggests something far messier: weak oversight, fuzzy statistics, rising disorder, and a public policy that keeps asking citizens to trust what it does not fully measure. The claim that these facilities are “safe” has become a rhetorical […]

When ‘Supervised’ Doesn’t Mean Safe: A Snapshot on Canadian Drug Consumption Facilities. Read More »

Are Canadian Drug Consumption Sites a Crime Magnet?

Some Research… Toronto’s Supervised Consumption Sites and Local Crime Abstract Importance: Beginning in August 2017, 9 overdose prevention sites and supervised consumption sites (OPS/SCS) began operating in Toronto, Canada. Following years of community pushback stating that these sites increased local crime and disorder, they were closed in March 2025. Objective: To examine the association between OPS/SCS and

Are Canadian Drug Consumption Sites a Crime Magnet? Read More »

Dealers Targeting Heroin and Cocaine Users Outside Glasgow’s First Drug Consumption Room

Glasgow fix room dealers are openly flogging heroin and cocaine to addicts at the gates of Britain’s first safer drug consumption facility. Pushers target vulnerable users outside The Thistle Hub, a £2.3 million a year centre in the Calton district. Campaigners say it is an open secret. Authorities, they warn, look the other way. Drug

Dealers Targeting Heroin and Cocaine Users Outside Glasgow’s First Drug Consumption Room Read More »

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series (Canada)

  Background and aims Evidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual-level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing on 31 March 2025. This study

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series (Canada) Read More »

Opioid Addiction Prevention: Critical Lessons from Treatment Failures

The opioid crisis continues to devastate communities across Canada and beyond, with recent research highlighting alarming treatment retention failures that underscore why prevention must be our primary defence. A comprehensive study examining opioid agonist therapy amongst First Nations people in Ontario reveals shocking statistics that every family, educator, and community leader must understand. The Stark

Opioid Addiction Prevention: Critical Lessons from Treatment Failures Read More »

Examining Melbourne Injecting Room Effectiveness – Part 2: Overdose Rates

  The Melbourne injecting room has come under sharp criticism following revelations of astonishing overdose rates. Over an 18-month period after the facility’s opening in July 2018, startling statistics showed 23.5 overdoses per 1,000 heroin injections at the MSIR facility, a figure that eclipsed comparable street overdose statistics of just 0.23 per 1,000 injections. This equates

Examining Melbourne Injecting Room Effectiveness – Part 2: Overdose Rates Read More »

Examining Injecting Room Effectiveness in Melbourne

Advocates often promote injecting rooms, also called supervised injection facilities, as a way to minimise drug-related harm. Proponents suggest these facilities save lives and reduce community issues such as public drug use and discarded needles. However, a closer look at available data raises concerns about injecting room effectiveness, particularly in reducing fatalities or improving conditions

Examining Injecting Room Effectiveness in Melbourne Read More »

Scroll to Top